Independent minds. Global perspective. A publication for the builders
Biotechnology / Oxford, United Kingdom

Li-Yao Huang.

Co-founder
FinalDose

Li-Yao Huang is a founder of FinalDose, which is researching programmable drug technology. He holds a biochemistry doctorate from Oxford and worked as a postdoctoral researcher at the MRC Weatherall Institute of Molecular Medicine. His research background includes cancer cell screening and mechanisms related to resistance to existing therapies.

Public-source researchLast checked 1 source ↘
THE STORY, IN CONTEXT

Li-Yao Huang and the story of FinalDose.

FinalDose's public launch proposes a drug platform intended to recognise selected genetic information inside cells. It describes an early technical concept and a broad future research agenda. Huang's cancer biology experience supplies context for that work, but the source does not establish a treatment approved for patients or a cure for cancer. The profile therefore records the research direction without reproducing the launch's universal therapeutic claims or presenting preclinical ideas as clinical results.

FROM THE PUBLIC RECORD

Public advice & further reading.

No personal advice is attributed in this profile: a verifiable public advice source has not yet been established. The company and activity facts above remain separately sourced.

Suggest a first-person interview or essay ↗
EVIDENCE IN PLAIN SIGHT

Sources & attribution.

  1. 01
    FinalDose — Y Combinator company and active founder profile

    Public active-founder biography, current company status and description, and founding-team launch accounts. Company or team statements are attributed accounts, not independently audited performance results.

    www.ycombinator.com
About this profile

Independently researched from the public sources above. Featured people and companies are not affiliated with BusinessBlogz. Source dates and attribution provide context for the information shown; business claims remain attributed to their original source. Role and company details can change after review. The initials graphic is editorial artwork, not a photograph.

Request a correction or update ↗
KEEP EXPLORING

More builders in Biotechnology.

Explore the sector ↗